Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
national top stories
boston
boston blog main
boston top stories
national
san diego blog main
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
cancer
centers for medicare and medicaid services
clinical trials
cms
cologuard
colon cancer
colorectal cancer
dna
duchenne muscular dystrophy
dyne therapeutics
event
exact sciences
facioscapulohumeral muscular dystrophy
fda
food and drug administration
gene therapy
healthcare
joshua brumm
kaleido biosciences
life science
medicare
muscular dystrophy
myotonic dystrophy type 1
new york blog main
rare disease drugs
romesh subramanian
What
early
4
×
sciences
bird
breakthroughs
life
xcelerating
accelerating
adversity
ago
attend
beats
biomedical
biopharma's
biopharma’s
biotechs
boston
cold
conference
considering
data
dealing
diego’s
digital
discussed
diseases
drug
dyne
ending
ends
exact
expected
experimental
eyes
flu
forecasts
future
genetic
genomics
having
health
Language
unset
Current search:
early
×
biotech
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference
@xconomy.com
6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up
